Episode 1: Redefining Precision Oncology: Imaging Innovations Driving Clinical Trials
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"url": "https://www.fortrea.com/insights/podcasts/imaging-precision-oncology-podcast",
"name": "Precision Oncology Imaging and Clinical Trial Design Insights |Podcast",
"description": "Listen to Fortrea Insights as experts explore the role of imaging in precision oncology clinical trials, highlighting how molecular imaging, radiomics, and radiogenomics are transforming patient selection and trial design. This podcast discusses how advanced imaging techniques enable earlier response detection, improve imaging endpoints in clinical trials, and support more personalized cancer treatment strategies. Topics include the use of precision oncology imaging in identifying the right patients, optimizing oncology clinical trial design, and integrating technologies such as PSMA PET imaging in prostate cancer. The episode provides practical insights into how imaging-driven approaches are enhancing clinical decision-making, improving trial efficiency, and advancing the future of precision oncology."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Podcasts",
"item": "https://www.fortrea.com/insights/podcasts"
},
{
"@type": "ListItem",
"position": 4,
"name": "Imaging in Precision Oncology Podcast",
"item": "https://www.fortrea.com/insights/podcasts/imaging-precision-oncology-podcast"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/"
]
},
{
"@type": "PodcastSeries",
"@id": "https://www.fortrea.com/insights/podcasts/imaging-precision-oncology-podcast#podcastseries",
"name": "Imaging in Precision Oncology Podcast",
"url": "https://www.fortrea.com/insights/podcasts/imaging-precision-oncology-podcast",
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"description": "Listen to how imaging is redefining precision oncology clinical trials by enabling more accurate patient selection and earlier detection of treatment response. This episode explores the integration of molecular imaging, radiomics, and radiogenomics into oncology clinical trial design, helping sponsors identify the right patient populations and improve study outcomes. Experts discuss the growing importance of imaging endpoints in clinical trials, the role of technologies such as PSMA PET imaging in prostate cancer, and how imaging-driven insights support personalized cancer treatment strategies. The conversation also highlights how these innovations are improving trial efficiency, accelerating decision-making, and advancing the future of precision oncology..",
"thumbnailUrl": "https://www.fortrea.com/sites/default/files/2025-10/podcast-logo.png"
},
{
"@type": "PodcastEpisode",
"@id": "https://www.fortrea.com/insights/podcasts/imaging-precision-oncology-podcast",
"name": "Imaging in Precision Oncology: Advancing Clinical Trials with Imaging Biomarkers",
"url": "https://www.fortrea.com/insights/podcasts/imaging-precision-oncology-podcast",
"datePublished": "2025-08-20",
"description": "Listen to this episode of the Fortrea Insights podcast as experts explore how imaging innovations are redefining precision oncology clinical trials. The discussion highlights the growing role of molecular imaging, including PSMA PET in prostate cancer, and the integration of AI-driven radiomics to improve patient selection and early response detection. It also examines how imaging endpoints are shaping oncology clinical trial design, alongside emerging approaches such as theranostics and the alignment of imaging with liquid biopsy data. With insights into regulatory considerations and real-world applications, this episode provides a comprehensive view of how advanced imaging technologies are driving more precise, efficient, and personalized cancer research..",
"partOfSeries": {
"@id": "https://www.fortrea.com/insights/podcasts/imaging-precision-oncology-podcast#podcastseries"
},
"creator": {
"@id": "https://www.fortrea.com/insights/podcasts/imaging-precision-oncology-podcast#host"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
}
},
{
"@type": "Person",
"@id": "https://www.fortrea.com/insights/podcasts/imaging-precision-oncology-podcast#dr-laura-vidal",
"name": "Dr. Laura Vidal",
"jobTitle": "VP of Oncology",
"worksFor": {
"@id": "https://www.fortrea.com/#organization"
},
"knowsAbout": [
"Precision oncology",
"Oncology clinical trials",
"Imaging biomarkers",
"Cancer research",
"Clinical trial design",
"Targeted therapies"
]
}
]
}
https://www.fortrea.com/insights/imaging-precision-oncology-podcast